{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:58:22Z","timestamp":1784303902542,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.freeradbiomed.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T15:24:43Z","timestamp":1328973883000},"page":"1294-1306","source":"Crossref","is-referenced-by-count":59,"title":["Resveratrol potentiates cytochrome P450 2d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse"],"prefix":"10.1016","volume":"52","author":[{"given":"Garima","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhuti","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharawan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra Kumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0010","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuint.2011.07.009","article-title":"Tiny non-coding RNAs in Parkinson's disease: implications, expectations and hypes","volume":"59","author":"Srivastava","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00441-004-0975-6","article-title":"Parkinson's disease: clinical aspects","volume":"318","author":"Klockgether","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0020","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ana.20051","article-title":"CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease","volume":"55","author":"Elbaz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0140-6736(92)91196-F","article-title":"Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease","volume":"339","author":"Smith","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/157015912799362779","article-title":"A current review of cypermethrin-induced neurotoxicity and nigrostriatal dopaminergic neurodegeneration","volume":"10","author":"Singh","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0161-813X(02)00092-X","article-title":"Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype","volume":"23","author":"Thiruchelvam","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/toxsci\/kfn028","article-title":"Response to \"Paraquat: the red herring of Parkinson's disease research\"","volume":"103","author":"LoPachin","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","article-title":"Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?","volume":"873","author":"Thiruchelvam","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0050","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","article-title":"Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats","volume":"20","author":"Cicchetti","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.01.060","article-title":"Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration","volume":"1081","author":"Patel","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.expneurol.2010.02.007","article-title":"Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration","volume":"223","author":"Kachroo","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0065","first-page":"385","article-title":"Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age","volume":"6","author":"Corasaniti","year":"1991","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0070","first-page":"406","article-title":"Drug-metabolizing cytochrome P450s in the brain","volume":"27","author":"Miksys","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/rej.2009.0850","article-title":"The Expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2, 3,6-tetrahydropyridine-induced Parkinson's Disease phenotype and nicotine-mediated neuroprotection","volume":"12","author":"Singh","year":"2009","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0080","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1006\/bbrc.1998.9232","article-title":"Dopamine formation from tyramine by CYP2D6","volume":"249","author":"Hiroi","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FPC.0b013e32801a3c10","article-title":"CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited","volume":"17","author":"Ozdemir","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00008571-200303000-00007","article-title":"Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6","volume":"13","author":"Yu","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2009.09.062","article-title":"The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: an in vitro study","volume":"626","author":"Bromek","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0100","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2011.07339.x","article-title":"Cytochrome P450 mediates dopamine formation in the brain in vivo","volume":"118","author":"Bromek","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10408440701215233","article-title":"Toxicological significance of mechanism-based inactivation of cytochrome P450 enzymes by drugs","volume":"37","author":"Masubuchi","year":"2007","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0110","first-page":"895","article-title":"The neurotoxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine (MPTP) induces changes in the heme spin state of microsomal cytochrome P-450","volume":"22","author":"Shahi","year":"1990","journal-title":"Biochem. Int."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1460-9568.2010.07142.x","article-title":"Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4-phenylpyridinium toxicity in SH-SY5Y neuronal cells","volume":"31","author":"Mann","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0120","doi-asserted-by":"crossref","first-page":"14186","DOI":"10.1074\/jbc.M700827200","article-title":"Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain","volume":"282","author":"Castello","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s11064-006-9255-z","article-title":"Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat","volume":"32","author":"Mokni","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0130","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1073\/pnas.0610068104","article-title":"Resveratrol stimulates AMP kinase activity in neurons","volume":"104","author":"Dasgupta","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0135","first-page":"227","article-title":"Evidence for resveratrol-induced preservation of brain mitochondria functions after hypoxia-reoxygenation","volume":"29","author":"Morin","year":"2003","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","article-title":"Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons","volume":"37","author":"Parker","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/rcm.918","article-title":"Liquid chromatography\/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate","volume":"17","author":"Yu","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","article-title":"Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse","volume":"50","author":"Singhal","year":"2011","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neurobiolaging.2010.02.018","article-title":"Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood","volume":"33","author":"Singh","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0160","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/toxsci\/kfr115","article-title":"Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations","volume":"122","author":"Singh","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4347(93)80429-8","article-title":"Simultaneous determination of paraquat and diquat in human tissues by high-performance liquid chromatography","volume":"617","author":"Ito","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00216-009-2929-z","article-title":"Quantification of Paraquat, MPTP, and MPP+ in brain tissue using microwave-assisted solvent extraction (MASE) and high-performance liquid chromatography-mass spectrometry","volume":"395","author":"Winnik","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0021-9673(93)80578-V","article-title":"Determination of paraquat in rat brain by high-performance liquid chromatography","volume":"643","author":"Corasaniti","year":"1993","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0180","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1177\/153537020623100908","article-title":"Metallothionein-3 is a component of a multiprotein complex in the mouse brain","volume":"231","author":"El Ghazi","year":"2006","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0190","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1124\/dmd.105.008870","article-title":"Expression, purification, and characterization of mouse CYP2D22","volume":"34","author":"Yu","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12035-010-8111-y","article-title":"Resveratrol as a therapeutic agent for neurodegenerative diseases","volume":"41","author":"Sun","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(02)03543-6","article-title":"Resveratrol protects against global cerebral ischemic injury in gerbils","volume":"958","author":"Wang","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0205","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3945\/jn.110.123505","article-title":"Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells","volume":"140","author":"Lin","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0210","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1023\/A:1021414129280","article-title":"Human, rat, and mouse metabolism of resveratrol","volume":"19","author":"Yu","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0215","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2006.03.190","article-title":"Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity","volume":"344","author":"Yanez","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuint.2008.11.001","article-title":"Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol","volume":"54","author":"Chang","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2006.06.096","article-title":"Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus","volume":"1111","author":"Gao","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0230","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1523\/JNEUROSCI.23-07-02744.2003","article-title":"Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2","volume":"23","author":"Avshalumov","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/27919","article-title":"Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons","volume":"394","author":"Fiorillo","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00436932","article-title":"Measurement of glucose-6-phosphate dehydrogenase and glutathione reductase activity in patients with paracoccidioidomycosis treated with ketoconazole","volume":"104","author":"Barraviera","year":"1988","journal-title":"Mycopathologia"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0245","doi-asserted-by":"crossref","first-page":"C12","DOI":"10.1152\/ajpcell.00314.2006","article-title":"The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic","volume":"293","author":"Scatena","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0250","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1522-7146(1996)11:3<127::AID-JBT4>3.0.CO;2-M","article-title":"Inhibition of mitochondrial function in isolated rat liver mitochondria by azole antifungals","volume":"11","author":"Rodriguez","year":"1996","journal-title":"J. Biochem. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0255","first-page":"1","article-title":"Localization, regulation, and function of metallothionein-III\/growth inhibitory factor in the brain","volume":"55","author":"Sogawa","year":"2001","journal-title":"Acta. Med. Okayama"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-4165(02)00325-2","article-title":"Protective effect of metallothionein-III on DNA damage in response to reactive oxygen species","volume":"1573","author":"You","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10048-011-0294-5","article-title":"Up-regulation of metallothionein gene expression in parkinsonian astrocytes","volume":"12","author":"Michael","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.taap.2008.04.019","article-title":"Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in aPI3K and ERK\/Nrf2-dependent manner","volume":"231","author":"Hwang","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/exnr.1997.6752","article-title":"Neural heme oxygenase-1 expression in idiopathic Parkinson's disease","volume":"150","author":"Schipper","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0280","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.freeradbiomed.2010.02.024","article-title":"Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED). Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2\/Trx axis","volume":"48","author":"Niso-Santano","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0285","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1080\/15287390500226987","article-title":"The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis","volume":"68","author":"Yang","year":"2005","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.02.031","article-title":"Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease","volume":"1328","author":"Khan","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.etp.2007.10.008","article-title":"Ketoconazole-induced testicular damage in rats reduced by Gentiana extract","volume":"59","author":"Amin","year":"2008","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0300","doi-asserted-by":"crossref","unstructured":"Mangano, E. N.; Litteljohn, D.; So, R.; Nelson, E.; Peters, S.; Bethune, C.; Bobyn, J.; Hayley, S. Interferon-\u03b3 plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol. Aging; in press. doi:10.1016\/j.neurobiolaging.2011.02.016.","DOI":"10.1016\/j.neurobiolaging.2011.02.016"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0305","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1471-4159.2006.03923.x","article-title":"Temporal effects of paraquat\/maneb on microglial activation and dopamine neuronal loss in older rats","volume":"98","author":"Saint-Pierre","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0310","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1172\/JCI110982","article-title":"Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells","volume":"72","author":"Loose","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0315","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.1017820108","article-title":"Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism","volume":"108","author":"Ros-Bernal","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0320","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0192-0561(92)90145-B","article-title":"Lack of immunosuppression by ketoconazole and itraconazole","volume":"14","author":"Cools","year":"1992","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0325","first-page":"293","article-title":"The TRIF\/TBK1\/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects","volume":"66","author":"Kim","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0330","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/taap.1998.8467","article-title":"Ketoconazole-induced apoptosis through P53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines","volume":"153","author":"Ho","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0335","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1745-7254.2007.00666.x","article-title":"Inhibition of caspases and intracellular free Ca2+ concentrations are involved in resveratrol protection against apoptosis in rat primary neuron cultures","volume":"28","author":"Gong","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0340","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.freeradbiomed.2008.07.002","article-title":"Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity","volume":"45","author":"Chao","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0345","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1471-4159.2009.06564.x","article-title":"Resveratrol reduces glutamate-mediated monocyte chemotactic protein-1 expression via inhibition of extracellular signal-regulated kinase 1\/2 pathway in rat hippocampal slice cultures","volume":"112","author":"Lee","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2012.02.005_bb0350","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s11064-004-6883-z","article-title":"Resveratrol protects against neurotoxicity induced by kainic acid","volume":"29","author":"Wang","year":"2004","journal-title":"Neurochem. Res."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584912000822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584912000822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T15:02:37Z","timestamp":1713538957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584912000822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0891584912000822"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.02.005","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}